Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating innate and adaptive immunity in oncolytic virus therapy
Kristin DePeaux, Greg M. Delgoffe
Trends in cancer (2023) Vol. 10, Iss. 2, pp. 135-146
Open Access | Times Cited: 13

Showing 13 citing articles:

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
Liping Zhong, Lu Gan, Bing Wang, et al.
Cell (2025)
Open Access | Times Cited: 2
GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer
Yujing Xuan, Wenyi Yan, Rui Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming
Qingzhe Yang, Yongheng Shu, Yanwei Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report
Xiaoming Zhang, Jingyu Chen, Jie Sun, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 3
Shifting the paradigm: engaging multicellular networks for cancer therapy
Joyce Hu, Paolo A. Ascierto, Alessandra Cesano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas
Georgios M. Stergiopoulos, Susanna C. Concilio, Evanthia Galanis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 952-991
Closed Access | Times Cited: 3
Immunotherapy for colorectal cancer
Bing Yu, Jian Kang, Hong Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Yigang Wang, Yaru Zhao, Xiaoyan Wang, et al.
Research Square (Research Square) (2024)
Open Access
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Yaru Zhao, Huihui Liu, Zhan Qi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry
Wenxun Dong, Ying Luo, Daqian He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Focused Ultrasound in Cancer Immunotherapy: A Review of Mechanisms and Applications
S. Labib, Robert K. Bright, Jingfei Liu
Ultrasound in Medicine & Biology (2024) Vol. 51, Iss. 1, pp. 1-14
Closed Access
Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges
Yan Zhang, Xinyu Shi, Yifan Shen, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV–GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
Diwakar Davar, Benedito A. Carneiro, Grace K. Dy, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009336-e009336
Open Access
Page 1

Scroll to top